GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma

Clinical trial NCT05352542 · TERMINATED

Trial details

NCT number: NCT05352542
Sponsor: jianming xu
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma

Start date: 2022-05-19
Primary completion: 2024-07-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.